Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele
- PMID: 17635185
- DOI: 10.1111/j.1472-8206.2007.00501.x
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele
Abstract
In the present study, we aimed to analyze the potential relevance of the polymorphism in the promoter region of the serotonin transporter (SERT or 5-HTT) gene (5-HTTLPR) and the risk of suffering major depression (MDD) in a population of patients previously genotyped for CYP2C9. Seventy white European psychiatric outpatients suffering from MDD and a group of 142 healthy volunteers (HVs) were studied. The frequency of subjects carrying the 5-HTTLPR-S allele was higher (P < 0.05) among MDD than in HV. The odds ratio associated with 5-HTTLPR-S allele was 2.03 for the MDD patients in comparison with the HV group. Previously, we found in this population that the CYP2C9*3 allele frequency was higher among this population of MDD patients than in HV. The frequency of subjects with the combination 5-HTTLPR-S and CYP2C9*3 alleles was higher (P < 0.01, odds ratio 3.47) in MDD than in HV. The present findings provide preliminary evidence about the greater risk of suffering MDD for individuals carrying both 5-HTTLPR-S and CYP2C9*3 alleles.
Similar articles
-
CYP2C9 gene and susceptibility to major depressive disorder.Pharmacogenomics J. 2003;3(5):300-2. doi: 10.1038/sj.tpj.6500197. Pharmacogenomics J. 2003. PMID: 14583800
-
Serotonin transporter polymorphism in Croatian patients with major depressive disorder.Psychiatr Danub. 2006 Jun;18(1-2):83-9. Psychiatr Danub. 2006. PMID: 16804504
-
Association between major depressive disorder and a functional polymorphism of the 5-hydroxytryptamine (serotonin) transporter gene: a meta-analysis.Psychiatr Genet. 2010 Apr;20(2):49-58. doi: 10.1097/YPG.0b013e328335112b. Psychiatr Genet. 2010. PMID: 20016401
-
Genes, stress, and depression.Metabolism. 2005 May;54(5 Suppl 1):16-9. doi: 10.1016/j.metabol.2005.01.007. Metabolism. 2005. PMID: 15877307 Review.
-
Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant.In Vivo. 2011 Nov-Dec;25(6):895-901. In Vivo. 2011. PMID: 22021682 Review.
Cited by
-
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Neuroimage. 2010 Feb 1;49(3):2588-95. doi: 10.1016/j.neuroimage.2009.10.037. Epub 2009 Oct 21. Neuroimage. 2010. PMID: 19853044 Free PMC article.
-
hsa-miR-3177-5p and hsa-miR-3178 Inhibit 5-HT1A Expression by Binding the 3'-UTR Region in vitro.Front Mol Neurosci. 2019 Jan 31;12:13. doi: 10.3389/fnmol.2019.00013. eCollection 2019. Front Mol Neurosci. 2019. PMID: 30766477 Free PMC article.
-
Role of pharmacogenomics in drug discovery and development.Indian J Pharmacol. 2008 Aug;40(4):137-43. doi: 10.4103/0253-7613.43158. Indian J Pharmacol. 2008. PMID: 20040945 Free PMC article.
-
CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.Br J Clin Pharmacol. 2014 Apr;77(4):673-83. doi: 10.1111/bcp.12227. Br J Clin Pharmacol. 2014. PMID: 24033670 Free PMC article. Review.
-
Gene-environment interaction in major depression: focus on experience-dependent biological systems.Front Psychiatry. 2015 May 8;6:68. doi: 10.3389/fpsyt.2015.00068. eCollection 2015. Front Psychiatry. 2015. PMID: 26005424 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources